Document is current

Any future updates will be listed below

Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study

Crossref DOI link: https://doi.org/10.1186/s13075-023-03158-9

Published Online: 2023-09-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark